The data demonstrate, for the first time, positive beta‐cell survival effects of enzymatically stabilized PP peptide analogs, coupled with sustained actions to reduce food intake, endorsing potential therapeutic promise of PP analogs for obesity‐derived forms of diabetes. The gene discussed is PPY; the disease is obesity due to melanocortin 4 receptor deficiency.